Company Information
USD
91.25
- (-1.8%)
NYSE:RVTY, REVVITY INC
Industry: Diagnostics & Research
End of Day: 9 May 2025 GMT-4
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
Address
940 Winter Street
Website
Classification
Sector
Healthcare
Industry Group
Medical Diagnostics & Research
Industry
Diagnostics & Research
Key Executives
Dr. Sophie V. Vandebroek, PhD
Director
Dr. Sylvie Gregoire,Pharm.D.
Director
Mr. Michael A Klobuchar
Director
Mr. Alexis P. Michas
Chairman of the Board/Director
Mr. Joel S. Goldberg
General Counsel/Secretary/Senior VP, Divisional
Dr. Peter Barrett,PhD
Director
Mr. Tajinder Vohra
Senior VP, Divisional
Dr. Frank R. Witney,, PhD
Director
Ms. Pascale Witz, M. Sc.,M.B.A.
Director
Mr. Daniel R. Tereau
Senior VP, Divisional
Mr. Michel Vounatsos
Director
Dr. Prahlad R. Singh
CEO/Director/President
Mr. Samuel R. Chapin
Director
Ms. Miriame Victor
Other Executive Officer/Senior VP
Ms. Michelle McMurry-Heath
Director
Mr. Maxwell Krakowiak
CFO/Senior VP
Ms. Anita Gonzales
Controller/Vice President
Ownership
Institution Holdings
T. Rowe Price Investment Management,Inc.
15,643,020 (12.663%)
Vanguard Group Inc
14,177,103 (11.477%)
Select Equity Group LP
11,272,417 (9.125%)
BlackRock Inc
8,686,672 (7.032%)
Janus Capital Management LLC
8,031,093 (6.501%)
Capital Research Global Investors
7,666,782 (6.206%)
Capital Research and Management Company
7,646,145 (6.190%)
Capital Group
6,136,863 (4.968%)
HHG PLC
5,454,428 (4.415%)
State Street Corporation
5,184,664 (4.197%)
Individual Holdings
Dr. Prahlad R. Singh
102,270 (0.083%)
Mr. Alexis P. Michas
55,604 (0.045%)
Mr. Joel S. Goldberg
40,900 (0.033%)
Mr. Tajinder Vohra
26,113 (0.021%)
Dr. Peter Barrett,PhD
21,406 (0.017%)
Dr. Sylvie Gregoire,Pharm.D.
20,482 (0.016%)
Mr. Samuel R. Chapin
15,789 (0.013%)
Mr. Daniel R. Tereau
13,246 (0.011%)
Ms. Miriame Victor
10,470 (0.009%)
Ms. Pascale Witz, M. Sc.,M.B.A.
9,098 (0.007%)
Funds Holdings
T. Rowe Price Capital Appreciation Fund
9,979,653 (8.079%)
Vanguard Total Stock Market Index Fund
3,893,721 (3.152%)
Vanguard US Total Market Shares ETF
3,893,721 (3.152%)
Janus Mid Cap Growth Tr
3,773,624 (3.055%)
Janus Henderson Enterprise Fund
3,773,624 (3.055%)
Vanguard Institutional 500 Index Trust
3,050,334 (2.469%)
Vanguard Mid-Cap Index Fund
2,764,105 (2.238%)
JNL/T. Rowe Price Capital AppreciationFd
2,385,246 (1.931%)
Pictet-Security
1,549,212 (1.254%)
VY® T. Rowe Price Capital Appre Port
1,505,519 (1.219%)
Make Smart Investment Choices
GoodWhale Pte. Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
